The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae.
Open accessAbstract
The antiphosphocholine (PC) antibody in normal mouse sera (NMS) provides protection against intravenous infection with encapsulated strain WU2 of type 3 Streptococcus pneumoniae. Mice unable to make anti-PC antibody, as a result of suppression with anti-T-15 idiotype or inheritance of the xid gene of CAB/N mice, are highly susceptible to infection with strain WU2. Mice inheriting the xid gene can be protected with NMS from immunologically normal mice or with IgM hybridoma anti-PC antibody. The protective effect of NMS can be removed with PC-containing immunoabsorbents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES
Avery, O. T., MacLeod, C. M., & McCarty, M. (1944) · Journal of Experimental Medicine · doi:10.1084/jem.79.2.137 · Cited by 2,683
A SEROLOGICAL DIFFERENTIATION OF HUMAN AND OTHER GROUPS OF HEMOLYTIC STREPTOCOCCI
Lancefield, R. C. (1933) · Journal of Experimental Medicine · doi:10.1084/jem.57.4.571 · Cited by 1,341
Avery, O. T., MacLeod, C. M., & McCarty, M. (2017) · Klassische Texte der Wissenschaft · doi:10.1007/978-3-662-47150-0_2 · Cited by 756
PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES
MacLeod, C. M., Hodges, R. G., Heidelberger, M., & Bernhard, W. G. (1945) · Journal of Experimental Medicine · doi:10.1084/jem.82.6.445 · Cited by 518
Affinity labeling of a phosphorylcholine binding mouse myeloma protein
Chesebro, B., & Metzger, H. (1972) · Biochemistry · doi:10.1021/bi00755a014 · Cited by 344
GENETIC CONTROL OF THE ANTIBODY RESPONSE TO TYPE III PNEUMOCOCCAL POLYSACCHARIDE IN MICE
Amsbaugh, D. F., Hansen, C. T., Prescott, B., Stashak, P. W., Barthold, D. R., & Baker, P. J. (1972) · The Journal of Experimental Medicine · doi:10.1084/jem.136.4.931 · Cited by 343
Self-citationLieberman, R., Potter, M., Mushinski, E. B., Humphrey, W., & Rudikoff, S. (1974) · The Journal of Experimental Medicine · doi:10.1084/jem.139.4.983 · Cited by 245
Scher, I., Ahmed, A., Strong, D. M., Steinberg, A. D., & Paul, W. E. (1975) · The Journal of experimental medicine · doi:10.1084/jem.141.4.788 · Cited by 210
Specific Inhibition of Plaque Formation to Phosphorylcholine by Antibody against Antibody
Cosenza, H., & Köhler, H. (1972) · Science · doi:10.1126/science.176.4038.1027 · Cited by 196
Scher, I., Steinberg, A. D., Berning, A. K., & Paul, W. E. (1975) · The Journal of experimental medicine · doi:10.1084/jem.142.3.637 · Cited by 195
Cited by
Martin, F., Oliver, A. M., & Kearney, J. F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00129-7 · Cited by 985
Self-citationControl of Early Viral and Bacterial Distribution and Disease by Natural Antibodies
Ochsenbein, A. F., Fehr, T., Lutz, C., Suter, M., Brombacher, F., Hengartner, H., & Zinkernagel, R. M. (1999) · Science · doi:10.1126/science.286.5447.2156 · Cited by 910
Origins and Functions of B-1 Cells with Notes on the Role of CD5
Berland, R., & Wortis, H. H. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064833 · Cited by 745
Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection
Malley, R., Henneke, P., Morse, S. C., Cieslewicz, M. J., Lipsitch, M., Thompson, C. M., Kurt-Jones, E., Paton, J. C., Wessels, M. R., & Golenbock, D. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0435928100 · Cited by 704
Biological properties of interleukin 10
Howard, M., & O'Garra, A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90153-x · Cited by 640
The importance of natural IgM: scavenger, protector and regulator
Ehrenstein, M. R., & Notley, C. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2849 · Cited by 635
Haas, K. M., Poe, J. C., Steeber, D. A., & Tedder, T. F. (2005) · Immunity · doi:10.1016/j.immuni.2005.04.011 · Cited by 628
Balázs, M., Martin, F., Zhou, T., & Kearney, J. F. (2002) · Immunity · doi:10.1016/s1074-7613(02)00389-8 · Cited by 624
Self-citationGriffin, D. O., Holodick, N. E., & Rothstein, T. L. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101499 · Cited by 615
THE ROLE OF COMPLEMENT AND COMPLEMENT RECEPTORS IN INDUCTION AND REGULATION OF IMMUNITY
Carroll, M. C. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.545 · Cited by 602
Positive Selection of Natural Autoreactive B Cells
Hayakawa, K., Asano, M., Shinton, S. A., Gui, M., Allman, D., Stewart, C. L., Silver, J., & Hardy, R. R. (1999) · Science · doi:10.1126/science.285.5424.113 · Cited by 576
Robbins, J. B., Austrian, R., Lee, C. J., Rastogi, S. C., Schiffman, G., Henrichsen, J., Makela, P. H., Broome, C. V., Facklam, R. R., Tiesjema, R. H., et al. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/148.6.1136 · Cited by 564
Boes, M., Prodeus, A. P., Schmidt, T., Carroll, M. C., & Chen, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2381 · Cited by 554
Natural antibodies and complement link innate and acquired immunity
Ochsenbein, A. F., & Zinkernagel, R. M. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01754-0 · Cited by 537
Hyams, C., Camberlein, E., Cohen, J. M., Bax, K., & Brown, J. S. (2010) · Infection and Immunity · doi:10.1128/iai.00881-09 · Cited by 458
CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity.
Ansel, K. M., Harris, R. B. S., & Cyster, J. G. (2002) · Immunity · doi:10.1016/s1074-7613(01)00257-6 · Cited by 449
Autoreactivity by design: innate B and T lymphocytes
Bendelac, A., Bonneville, M., & Kearney, J. F. (2001) · Nature Reviews Immunology · doi:10.1038/35105052 · Cited by 416
Self-citationThe Pneumococcus: Epidemiology, Microbiology, and Pathogenesis
Henriques-Normark, B., & Tuomanen, E. I. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a010215 · Cited by 411
Pericone, C. D., Overweg, K., Hermans, P. W. M., & Weiser, J. N. (2000) · Infection and Immunity · doi:10.1128/iai.68.7.3990-3997.2000 · Cited by 374
Brown, J. S., Hussell, T., Gilliland, S. M., Holden, D. W., Paton, J. C., Ehrenstein, M. R., Walport, M. J., & Botto, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012669199 · Cited by 370
Micro RNA 145 Targets the Insulin Receptor Substrate-1 and Inhibits the Growth of Colon Cancer Cells
Shi, B., Sepp-Lorenzino, L., Prisco, M., Linsley, P., deAngelis, T., & Baserga, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702806200 · Cited by 353
Biological properties of interleukin 10
Howard, M., O'Garra, A., Ishida, H., de Waal Malefyt, R., & De Vries, J. (1992) · Journal of Clinical Immunology · doi:10.1007/bf00918147 · Cited by 348
Natural Antibodies Bridge Innate and Adaptive Immunity
Panda, S., & Ding, J. L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400844 · Cited by 328
Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae
Berry, A. M., Yother, J., Briles, D. E., Hansman, D., & Paton, J. C. (1989) · Infection and Immunity · doi:10.1128/iai.57.7.2037-2042.1989 · Cited by 328
Self-citationAndersson, B., Porras, O., Hanson, L. A., Lagergard, T., & Svanborg-Eden, C. (1986) · Journal of Infectious Diseases · doi:10.1093/infdis/153.2.232 · Cited by 328
Swords, W. E., Buscher, B. A., Ver Steeg Ii, K., Preston, A., Nichols, W. A., Weiser, J. N., Gibson, B. W., & Apicella, M. A. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01952.x · Cited by 310
Briles, D. E., Forman, C., Hudak, S., & Claflin, J. L. (1982) · The Journal of experimental medicine · doi:10.1084/jem.156.4.1177 · Cited by 310
Self-citationPneumococcal Surface Protein A Inhibits Complement Activation by Streptococcus pneumoniae
Tu, A.-H. T., Fulgham, R. L., McCrory, M. A., Briles, D. E., & Szalai, A. J. (1999) · Infection and Immunity · doi:10.1128/iai.67.9.4720-4724.1999 · Cited by 284
Self-citationKim, S. J., Gershov, D., Ma, X., Brot, N., & Elkon, K. B. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020542 · Cited by 282
Impaired mast cell-dependent natural immunity in complement C3-deficient mice
Prodeus, A. P., Zhou, X., Maurer, M., Galli, S. J., & Carroll, M. C. (1997) · Nature · doi:10.1038/36586 · Cited by 277
IgM in microbial infections: Taken for granted?
Racine, R., & Winslow, G. M. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.06.003 · Cited by 268
Jayasekera, J. P., Moseman, E. A., & Carroll, M. C. (2007) · Journal of Virology · doi:10.1128/jvi.02128-06 · Cited by 264
Briles, D. E., Crain, M. J., Gray, B. M., Forman, C., & Yother, J. (1992) · Infection and Immunity · doi:10.1128/iai.60.1.111-116.1992 · Cited by 263
Self-citationWardemann, H., Boehm, T., Dear, N., & Carsetti, R. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011140 · Cited by 254
Complement activation in factor D-deficient mice
Xu, Y., Ma, M., Ippolito, G. C., Schroeder, H. W., Carroll, M. C., & Volanakis, J. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261428398 · Cited by 198
Type I interferons protect neonates from acute inflammation through interleukin 10–producing B cells
Zhang, X., Deriaud, E., Jiao, X., Braun, D., Leclerc, C., & Lo-Man, R. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062013 · Cited by 150
Pineda, M. A., Lumb, F., Harnett, M. M., & Harnett, W. (2014) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2014.03.003 · Cited by 88
Sakamoto, A., Matsuda, T., Kawaguchi, K., Takaoka, A., & Maruyama, M. (2017) · International Immunology · doi:10.1093/intimm/dxx054 · Cited by 10
Metadata
- Authors
- Briles, D. E., Nahm, M., Schroer, K., Davie, J., Baker, P., Kearney, J., & Barletta, R.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1981-03-01
- Volume
- 153
- Issue
- 3
- Pages
- 694-705
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2103516617
- Cited by
- 464
- References
- 23
- FWCI
- 15.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.